Topics
- Drug Target Discovery and Validation
- Drug Discovery Biology and Biotechnology
- Rational Drug Design
- Drug Screening Technology
- Early Phase Drug Discovery-Upstream
- Leading Drug Discovery Technology
- Breaking Biotherapy Discovery
- Frontier in Small Molecule Drug Discovery
- Traditional Chinese Medicine vs Natural Product based Drug Discovery
- Genome-Based Drug Discovery and Development
- Pipeline Update on IND against Major Diseases
- Late Phase Drug Discovery -Downstream
- New Drug Bioprocess and Production under GMP Standards
- Me-too Drug Discovery and Biosimilar
- Drug Discovery Integrative Services, Deal-Making, and Business Development
- Key Issues in IND Filing and Regulatory Approval Process
- Non-Human Drug Discovery
- Pharmaceutical R & D Management and Translational Sciences
- Pesticide Discovery and Development
- Veterinary Medicine Discovery and Development
- Aquaculture Biocides and Disease Prevention Drug Discovery
Who should Attend
Scientists and decision makers responsible for: Preclinical Development, R&D Discovery Development, Pharmaceutical Development, Screening Research, Product Development, Scientific Affairs Toxicology, Technology, Safety, Genetics, Chemistry and Medical Affairs.
